心力衰竭低钠血症的临床挑战。
Clinical challenge of hyponatremia in heart failure.
机构信息
Division of Cardiology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Missouri 63110, USA.
出版信息
J Hosp Med. 2012 Apr;7 Suppl 4:S6-10. doi: 10.1002/jhm.1913.
DOI:10.1002/jhm.1913
PMID:22489082
Abstract
Hyponatremia is a significant and independent predictor of outcomes including rehospitalization and mortality in patients with both acute decompensated heart failure (HF) and chronic HF. Even modest degrees of hyponatremia are associated with a poorer prognosis. Treatment options include fluid restriction and the vaptan class ("aquaretics") in select patients.
摘要
低钠血症是急性失代偿性心力衰竭（HF）和慢性 HF 患者结局（包括再住院和死亡）的一个重要且独立的预测因素。即使是轻度的低钠血症也与预后较差相关。治疗选择包括限制液体摄入和在特定患者中使用血管加压素类药物（“aquaretics”）。
Zotero 插件